Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials-Reference-Cited by-同舟云学术

Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials

Published:2024-02 Issue:10428 Volume:403 Page:741-755
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Wagenlehner Florian,Perry Caroline R,Hooton Thomas M,Scangarella-Oman Nicole E,Millns Helen,Powell Marcy,Jarvis Emily,Dennison Jeremy,Sheets Amanda,Butler Deborah,Breton John,Janmohamed Salim

Funder

BARDA

GSK

Publisher

Elsevier BV

Reference28 articles.

1. An introduction to the epidemiology and burden of urinary tract infections;Medina;Ther Adv Urol,2019

2. Diagnosis and treatment of acute uncomplicated cystitis;Colgan;Am Fam Physician,2011

3. Antimicrobial resistance trends in urine Escherichia coli isolates from adult and adolescent females in the United States from 2011 to 2019: rising ESBL strains and impact on patient management;Kaye;Clin Infect Dis,2021

4. Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution on uncomplicated lower urinary tract infection in women: a randomized clinical trial;Huttner;JAMA,2018

5. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases;Gupta;Clin Infect Dis,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics;Nature Reviews Microbiology;2024-09-09

2. Novel Antibiotics for Urinary Tract Infection (UTI): The EAGLE 2 and EAGLE-3 Trials for Uncomplicated UTI, and the CERTAIN-1 Trial for Complicated UTI;European Urology Focus;2024-08

3. Interactions between Zoliflodacin and Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enzymological Basis for Cellular Targeting;ACS Infectious Diseases;2024-07-31

4. A Review of Antibacterial Candidates with New Modes of Action;ACS Infectious Diseases;2024-07-17

5. ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics;Nature Reviews Microbiology;2024-06-03